Skip to main content
SpringerLink
Log in

Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

To study antitumor immunity in patients with choroidal melanoma, T cells were generated from the peripheral blood of choroidal melanoma patients by mixed lymphocyte/tumor cell culture (MLTC). Because autologous tumors are generally unavailable, an allogeneic choroidal melanoma cell line, OCM-1, was used as the specific stimulus. Lymphocyte cultures from 27 patients were characterized by cell-surface phenotypes, patterns of reactivity towards cells of the melanocytic origin and T-cell-receptor gene usage. Antimelanoma reactivity was found in cell-sorter-purified CD4+ and CD8+ T cell subsets. To analyze this reactivity, sorter-purified CD4+ and CD8+ cells from a MLTC were cloned by limiting dilution in the presence of exogenous interleukin-2 and interleukin-4 as well as irradiated OCM-1. Under these conditions, CD4+ T cells did not proliferate, perhaps because of the absence of antigen-presenting cells. However, CD8+ grew vigorously and 29 cytolytic CD8+ T cell clones were isolated. On the basis of their pattern of lysis of OCM-1, a skin melanoma cell line M-7 and its autologous lymphoblastoid cell line LCL-7, the clones were categorized into three groups. Group 1, representing 52% of the clones, lysed all three target cells, and are alloreactive. However, since OCM-1 and M-7 did not share class I antigens, these clones recognized cross-reactive epitope(s) of the histocompatibility locus antigen (HLA) molecule. Group 2, constituting 28% of the clones, lysed both the ocular and skin melanoma cell lines but not LCL-7, and were apparently melanoma-specific. Unlike classical HLA-restricted cytolytic T lymphocytes, these T cells might mediate the lysis of melanoma cells via other ligands or a more degenerate type of HLA restriction. For the latter, the HLA-A2 and -A28 alleles would have to act interchangeably as the restriction element for shared melanoma-associated antigen(s). Group 3, representing only 10% of the T cell clones, was cytotoxic only to OCM-1, but not to M-7 or LCL-7. These clones may recognize antigens unique to ocular melanoma cells. Our data suggest that choroidal melanoma patients can recognize melanoma-associated antigens common to both ocular and cutaneous melanoma cells, and presumbly their autologous tumor. Thus, choroidal melanoma, like its skin counterpart, may be responsive to immunotherapeutic regimens such as active specific or adoptive cellular immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anichini A, Fossati G, Parmiani G (1985) Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer 35: 683

    Google Scholar 

  2. Anichini A, Mazzocchi A, Fossati G, Parmiani G (1989) Cytotoxic T lymphocyte clones from peripheral bloods and from tumor site detect intratumor heterogeneity of emlanoma cells. Analysis of specificity and mechanism of interaction. J Immunol 142: 3692

    Google Scholar 

  3. Ashton N (1964) Primary tumours of the iris. Br J Ophthalmol 48: 650

    Google Scholar 

  4. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86: 7159

    Google Scholar 

  5. Berd D, Mastrangelo MJ (1988) Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide. Cancer Invest 6: 337

    Google Scholar 

  6. Brado R, Lauzurica P, deCastro LAJ (1990) T cell receptor Vβ gene usage in a human alloreactive response. J Exp Med 171: 1189

    Google Scholar 

  7. Brooks, CG, Urdal DL, Henney CS (1983) Lymphokine-driven differentiation of cytotoxic T-cell clones into cells with NK-like specificity: correlation with display of membrane molecules. Immunol Rev 72: 43

    Google Scholar 

  8. Carrel S, Schreyer M, Gross N, Zografos L (1990) Surface antigenic profile of uveal melanoma lesions analyzed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anticancer Res 10: 81

    Google Scholar 

  9. Char DH, Hollinshead A, Cogan DG, Ballantine E, Hogan MJ, Herberman RB (1974) Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma. N Engl J Med 291: 274

    Google Scholar 

  10. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989) Interaction ofStaphylococcus aureus toxin “superantigen” with human T cells. Proc Natl Acad Sci USA 86: 8941

    Google Scholar 

  11. Cochran AJ, Foulds WS, Damato BE, Trope GE, Morrison L, Lee WR (1985) Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma. Br J Ophthalmol 69: 171

    Google Scholar 

  12. Crowley NJ, Slingluff CL Jr, Darrow TL, Seigler HF (1990) Generation of human autologous melanoma-specific cytotoxic T cells using HLA-A2-matched allogeneic melanomas. Cancer Res 50: 492

    Google Scholar 

  13. Darrow TL, Slingluff CL, Seigler HF (1989) The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. J Immunol 142: 3329

    Google Scholar 

  14. Darrow TL, Slingluff CL Jr, Seigler HF (1989) The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol 142: 3329

    Google Scholar 

  15. DeVries JE, Spits H (1984) In vitro generation, isolation and analysis to phenotype and specificity. J Immunol 132: 510

    Google Scholar 

  16. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM (1988) Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 32: 239

    Google Scholar 

  17. Fuchs E (1910) Über Sarkum der Aderhaut nebst Bemerkungen über Nekrose der Uvea. Albrecht von Graefes Arch Klin Ophthalmol 77: 304

    Google Scholar 

  18. Halaban R, Kwon BS, Ghosh S, Bovis PD, Baird A (1988) bFCF as an autocrine growth factor for human melanomas. Oncogene Res 3: 177

    Google Scholar 

  19. Harel W, Li V, Morse A, Kan-Mitchell J, Ewoldsen MA, Mitchell MS (1990) Generation of melanoma-reactive T cell clones from patients treated with active specific immunotherapy. Proc Am Assoc Cancer Res 31: 253

    Google Scholar 

  20. Harning R, Koo GC, Szalay J (1989) Regulation of the metastasis of murine ocular melanoma by natural killer cells. Invest Ophthalmol Vis Sci 30: 1909

    Google Scholar 

  21. Hersey P, Bolhuis R (1987) Nonspecific MHC-unrestricted killer cells and their receptors. Immunol Today 8: 233

    Google Scholar 

  22. Hersey P, MacDonald MJ, Schibeci SD, Burns C (1986) Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures. Cancer Immunol Immunother 22: 15

    Google Scholar 

  23. Janeway Jr, CA (1989) The role of CD4 in T-cell activation: accesory molecule or co-recpetor? Immunol Today 10: 234

    Google Scholar 

  24. Jensen OA, Andersen SR (1974) Spontaneous regression of a malignant melanoma of the choroid. Acta Ophthalmol (Copenh) 52: 173

    Google Scholar 

  25. Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE (1989) Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Opthalmol Vis Sci 30: 829

    Google Scholar 

  26. Kan-Mitchell J, Rao N, Albert DM, Van Eldik LJ, Taylor CR (1990) S100 immunophenotypes of uveal melanomas. Invest Ophthalmol Vis Sci 31: 1492

    Google Scholar 

  27. Kawakami Y, Rosenberg SA, Lotze MT (1988) Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med 168: 2183

    Google Scholar 

  28. Kawasaki ES, Clark SC, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP (1988) Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci, USA, 85: 3698

    Google Scholar 

  29. Knisely TL, Niederkorn JY (1990) Immunologic evaluation of spontaneous regression of an intraocular murine melanoma. Invest Ophthalmol Vis Sci 31: 247

    Google Scholar 

  30. Lindahl KF, Wilson DB (1977) Histocompatibility antigen-activated cytotoxic T lymphocytes: II. Estimates of the frequency and specificity of precursors. J Exp Med 145: 508

    Google Scholar 

  31. Lopez de Castro JA, Strominger JL, Strong DM, Orr HT (1982) Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible immplications for the generation of HLA polymorphism. Proc Natl Acad Sci USA 79: 3813

    Google Scholar 

  32. Maniatis T, Fritsch EF, Sambrook J (eds) (1979) Molecular cloning. Cold Spring Harbor Laboratory, New York, p 188

    Google Scholar 

  33. Mann DW, McLauglin-Taylor E, Wallace RB, Forman J (1988) An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes. J Exp Med 168: 307

    Google Scholar 

  34. Mitchell MS (1990) Active specific immunotherapy with allogeneic melanoma lysates and the adjuvant DETOX. In: Biological agents in the treatment of cancer. NSW Government Printing Service, Ultimo, Australia, p 110

    Google Scholar 

  35. Mitchell MS, Kan-Mitchell J, Kempf RA, Harel W, Shau H, Lind S (1988) Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res 48: 5883

    Google Scholar 

  36. Mitchell MS, Kempf RA, Harel W, Hu E, Kan-Mitchell J, Boswell WD, Dean G, Stevenson L (1990) Active specific immunotherapy for melanoma. J Clin Oncol 8: 856

    Google Scholar 

  37. Newton FH (1965) Malignant melanoma of the choroid. Arch Ophthalmol 73: 198

    Google Scholar 

  38. Niederkorn JY (1987) T cell subsets involved in the rejection of metastases arising from intraocular melanomas in mice. Invest Ophthalmol Vis Sci 28: 1397

    Google Scholar 

  39. Nitta T, Oksenberg JR, Rao NA, Steinman L (1990) Tumor infiltrating lymphocytes in uveal melanoma predominantly express the T cell receptor gene, Vα7. Science 249: 672

    Google Scholar 

  40. Oksenberg JR, Stuart S, Begovich AB, Bell R, Erlich HA, Steinman L, Bernard CCA (1990) Nature 345: 344

    Google Scholar 

  41. Parmiani G, Anichini A, Fossati G (1990) Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? Immunol Today 82: 361

    Google Scholar 

  42. Rahi AHS (1983) Immunology of ocular tumours. In: Pathobiology of ocular disease. Dekker, New York, p 823

    Google Scholar 

  43. Reinherz E, Schlossman SF (1980) The differentiation and function of human T lymphocytes. Cell 19: 821

    Google Scholar 

  44. Roberts TE, Shipton U, Moore M (1986) Proliferation and cytotoxic responses of human peripheral blood lymphocytes to autologous malignant effusions. An analysis at the clonal level. Cancer Immunol Immunother 15: 227

    Google Scholar 

  45. Rosenberg SA (1990) Adoptive immunotherapy for cancer. Sci Am 262: 62

    Google Scholar 

  46. Shields JA, Augsburger JJ, Donoso LA, Bernardino VB Jr (1985) Hepatic metastasis and orbita recurrence of uveal melanoma after 42 years. Am J Ophthalmol 100: 666

    Google Scholar 

  47. Slovin SF, Lackman RD, Ferrone S, Kiely PE, Mastrangelo MJ (1986) Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas: I. Development, phenotype, and specificity. J Immunol 137: 3042

    Google Scholar 

  48. Spits H, Yssel H, Takebe Y, Arai N, Yokota T, Lee F, Arai K, Banchereau J, de Vries JE (1987) Recombinant interleukin 4 promotes the growth of human T cells. J Immunol 139: 1142

    Google Scholar 

  49. Sunba MSN, Rahi AHS, Morgan G (1980) Tumours of the anterior uveal: I. Metastasizing malignant melanoma of the iris. Arch Ophthalmol 98: 82

    Google Scholar 

  50. Sunba MSN, Rahi AHS, Morgan G, Holborow EJ (1980) Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with histological features of the tumour. Br J Ophthalmol 64: 576

    Google Scholar 

  51. Swain SL (1983) T cell subsets and their recognition of MHC class. Immunol Rev 74: 129

    Google Scholar 

  52. Taswell C, MacDonald HR, Cerottini J-C (1980) Clonal analysis of cytolytic T lymphocyte specificity: I. Phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens. J Exp Med 151: 1372

    Google Scholar 

  53. Thiele DL, Lipsky PE (1989) The role of cell surface recognition structures in the initiation of MHC-unrestricted “promiscuous” killing by T cells. Immunol Today 10: 375

    Google Scholar 

  54. Topalian SL, Rosenberg SA (1990) Tumor-infiltrating lymphocytes: evidence for specific immune reactions against growing cancers in mice and humans. Important Adv Oncol 58: 19

    Google Scholar 

  55. Vose BM, White W (1983) Tumor-reactive lymphocytes stimulated in mixed lymphocyte and tumor cultures. Clonal analysis of effector cells in cytotoxic and proliferative assays. Cancer Immunol Immunother 22: 107

    Google Scholar 

  56. Whitehead TP, Thorpe GH, Cater TJN, Groucutt C, Kricka I (1983) Enhanced luminescence procedure for sensitive determination of peroxidase-labelled conjugates in immunoassay. Nature 305: 158

    Google Scholar 

  57. Wolfel T, Klehmann E, Muller C, Schutt K, Zum Bushenfelde K-H M, Knuth A (1989) Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med 170: 797

    Google Scholar 

  58. Wraith DC (1987) The recognition of influenza A virus-infected cells by cytotoxic T lymphocytes. Immunol Today 8: 239

    Google Scholar 

  59. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL, Haflar DA (1990) Shared human T cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 248: 1016

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Norris 710, University of Southern California School of Medicine, 2025 Zonal Avenue, 90 033, Los Angeles, California, USA

    June Kan-Mitchell

  2. Department of Ophthalmology, Norris 710, University of Southern California School of Medicine, 2025 Zonal Avenue, 90 033, Los Angeles, California, USA

    Peter E. Liggett

  3. Department of Medicine, Norris 710, University of Southern California School of Medicine, 2025 Zonal Avenue, 90 033, Los Angeles, California, USA

    William Harel & Malcolm S. Mitchell

  4. Departments of Neurology and Pediatrics, Stanford University, Stanford, California, USA

    Lawrence Steinman, Taizo Nitta & Jorge R. Oksenberg

  5. Department of Medicine, Brown University, Providence, Rhode Island, USA

    Marshall R. Posner

Authors
  1. June Kan-Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter E. Liggett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William Harel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lawrence Steinman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Taizo Nitta
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jorge R. Oksenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marshall R. Posner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Malcolm S. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work is supported by National Institutes of Health research grants CA 36 233 and EY 9031, the Lucy Adams Memorial Fund and support from the Concern Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kan-Mitchell, J., Liggett, P.E., Harel, W. et al. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients. Cancer Immunol Immunother 33, 333–340 (1991). https://doi.org/10.1007/BF01756599

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01756599

Key words

Search

Navigation